Search Results
Mark W. Bellomy
Partner
Mark Bellomy is a partner in Wilson Sonsini Goodrich & Rosati’s Boston office, where he is a member of the technology transactions practice. Mark advises numerous domestic and international public and private biopharmaceutical, medtech, digital health, medical device, and life sciences companies on all of the transactions related to the discovery, development, supply, and commercialization of their products, technologies, and services. He counsels clients with respect to structuring and negotiating a wide range of arrangements designed to maximize the value of their businesses.
Miranda Biven
Partner
Miranda advises life sciences clients in partnering and licensing arrangements, M&A, and other transactions.
Nellie J. Brutocao
Partner
Nellie Brutocao is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. Her practice focuses on the life sciences industry, where she advises public and private companies on structuring, negotiating, and executing complex transactions involving the development, licensing, acquisition, monetization, and commercialization of innovative technologies and therapeutics. Her experience includes negotiating bespoke strategic collaborations and licensing arrangements; advising on the intellectual property and commercial aspects of mergers, acquisitions, and divestitures; and counseling clients on critical commercial and operational agreements. Nellie brings a practical, business-oriented approach to navigating complex legal and commercial issues and developing creative solutions that advance her clients’ strategic objectives.
Kenneth A. Clark
Partner
Ken focuses on life sciences clients and often acts as outside legal counsel to biotechnology companies and their boards.
James G. Clessuras
Partner
James assists clients with transactions driven by use or acquisition of technology and IP rights.
Farah B. Gerdes
Partner
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Daniel Glazer
Partner
Daniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
Gary R. Greenstein
Partner
Gary represents companies in transactions with record labels, music publishers, and program suppliers focusing on intellectual property, licensing, and commercial transactions.
Norm Hovijitra
Partner
Dr. Norm Hovijitra is a partner in the technology transactions practice at Wilson Sonsini Goodrich & Rosati. He advises emerging and established companies in the life sciences industry on legal and business issues associated with the development, manufacture, and commercialization of their products and technologies, including matters relating to intellectual property strategy and patents.
Daniel Keating
Partner
Daniel focuses on corporate and securities matters, including sophisticated domestic and international transactions.
Alex Key
Partner
Alex focuses on representing clients in the biotechnology, pharmaceutical, medical device, diagnostic, and digital health industries.
Jennifer M. McGrew
Partner
Jennifer helps innovative clients complete strategic technology transactions.
Scott A. McKinney
Partner
Scott focuses on complex commercial and technology transactions and frequently advises companies with new and emerging technologies.
Christopher A. Paniewski
Partner
Christopher focuses his practice on outsourcing transactions, commercial agreements, and technology-related transactions such as licensing and strategic relationships.
David Pirko
Partner
David represents innovative and leading life science companies and venture capital investors in strategic transactional and corporate matters.